United States · 
Who invested in Radionetics Oncology?
Radionetics Oncology's investors include DCVC and 5AM Ventures.
United States · Series A startup
Who invested in Radionetics Oncology
Funding summaryUpdated 26 Oct 2026
$53Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $53MAug 2023
- Investors
- 2
The rounds
- Aug 2023
Founders and team
From Radionetics Oncology's own website and the SEC filings it signed: 10 on the team.
- Paul GraysonChief Executive Officer
- Radionetics OncologyCEO
- Zachary HornbyCEO
- Alyssa LevinChief Financial Officer
- Ana KusnetzowExecutive Officeri
- Brett EwaldExecutive Officeri
- Dan EstesExecutive Officer, Directori
- Istvan MolnarExecutive Officeri
- Umesh GangadharmathExecutive Officeri
- Yunfei ZhuExecutive Officeri
On the board, as filediAndrew SchwabScott Struthers
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Radionetics Oncology
How much has Radionetics Oncology raised?
Radionetics Oncology has raised $53M across 1 round since 2023.
When did Radionetics Oncology last raise?
Radionetics Oncology's most recent round was a Series A of $53M in Aug 2023.
What was Radionetics Oncology's biggest round?
Its most recent round, $53M in Aug 2023, is also its largest on record.
Who backed Radionetics Oncology first?
Radionetics Oncology's first round on record, in Aug 2023, was backed by DCVC and 5AM Ventures.
What stage is Radionetics Oncology at?
Radionetics Oncology's latest named round is a Series A, in Aug 2023.
Where is Radionetics Oncology based?
Radionetics Oncology is based in the United States.
Companies like Radionetics Oncology
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.